Treatment of Panic Attacks
The recommended first-line treatment for panic attacks is cognitive behavioral therapy (CBT), with selective serotonin reuptake inhibitors (SSRIs) as the first-line pharmacological option when medication is needed or preferred. 1
Non-Pharmacological Treatment
Cognitive Behavioral Therapy
- CBT is the psychotherapy of first choice for panic attacks, with strong evidence supporting its efficacy
- Individual CBT sessions are preferred over group therapy due to superior clinical effectiveness
- Structured approach typically includes 12-20 sessions with key components:
- Education about anxiety and panic
- Cognitive restructuring to challenge distorted thinking patterns
- Graduated exposure to feared situations
- Relaxation techniques (deep breathing, progressive muscle relaxation)
- Homework assignments to practice skills
Alternative CBT Delivery Options
- If a patient declines face-to-face CBT, offer supported self-help based on CBT principles:
- Approximately 9 sessions over 3-4 months
- Self-help materials with therapist support (total of approximately 3 hours)
- Support provided via face-to-face meetings or telephone
Pharmacological Treatment
First-Line Medications
- SSRIs are the first-line pharmacological treatment for panic disorder 1, 2, 3
- Sertraline: Starting dose 25-50 mg daily, target dose up to 200 mg daily
- Escitalopram: 10-20 mg daily
- Fluoxetine: 10-20 mg daily
- Common side effects include nausea, diarrhea, headache, insomnia, and sexual dysfunction
- Start with lower doses and titrate slowly to minimize side effects
Alternative Medications
- SNRIs (e.g., venlafaxine) are suggested as an alternative first-line option 4, 1
- Benzodiazepines (e.g., alprazolam) should be reserved for:
- Benzodiazepines have rapid onset of action but carry risks of tolerance and dependence 6
Treatment Algorithm
Initial Assessment and Treatment Planning
- Determine severity of panic attacks and impact on functioning
- Screen for comorbid conditions (depression, other anxiety disorders)
- Discuss treatment options with patient
First-Line Treatment
- For mild to moderate panic disorder: Begin with CBT
- For moderate to severe panic disorder: Consider CBT plus SSRI
- If immediate symptom relief is needed: Consider short-term benzodiazepine while initiating other treatments
Monitoring and Adjustment
- Evaluate initial response after 2-3 weeks
- Assess full effect at 4-6 weeks using standardized anxiety assessment tools
- If inadequate response to SSRI after 4-6 weeks at adequate dose:
- Consider switching to another SSRI or SNRI
- Consider augmentation strategies for partial responders
Maintenance and Discontinuation
- Continue effective treatment for approximately 1 year following symptom remission
- When discontinuing medication, reduce dose gradually:
- For SSRIs: Reduce by no more than 25% every 1-2 weeks
- For benzodiazepines: Reduce by 25% every 1-2 weeks, with total tapering duration of 8-12 weeks
Special Considerations
Pitfalls to Avoid
- Abrupt discontinuation of medication (especially benzodiazepines) can lead to withdrawal symptoms
- Inadequate duration of treatment increases risk of relapse
- Failure to monitor systematically can lead to poor outcomes
- Overlooking comorbidities may require modification of treatment approach
Complementary Approaches
- Structured physical activity and exercise show benefit for anxiety reduction
- Breathing techniques and relaxation exercises can help manage acute symptoms
By following this evidence-based approach to treating panic attacks, clinicians can help patients achieve significant reduction in symptoms and improved quality of life.